NeurogesX, Inc. (NGSX) Posts Q3 Loss of 43c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NGSX Hot Sheet
Price: $0.01 --0%
Financial Fact:
Collaboration revenue: 2.25M
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Collaboration revenue: 2.25M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
NeurogesX, Inc. (NASDAQ: NGSX) reported Q3 loss of ($0.43), $0.01 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.89 million versus the consensus estimate of $3.14 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
